
NRx Pharmaceuticals Subsidiary to Acquire Stake in Florida Neuropsychiatry Clinic
NRx Pharmaceuticals' subsidiary HOPE Therapeutics is set to acquire a 49% stake in Cohen and Associates, a move expected to enhance revenue and expand its clinic network.
Read full story


























